Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis

Table 2 General baseline characteristics after propensity score matching (n = 30)

	Resection, n = 15	TACE, n = 15	Total, n = 30	P value
Age (yr)	68.9 ± 9.2	70.5 ± 9.9	69.7 ± 9.5	0.651
Gender, n (%)				0.651
Male	13 (86.7)	11 (73.3)	24 (80)
Female	2 (13.3)	4 (26.7)	6 (20)
BMI (kg/m2)	26.1 ± 4.3	26.3 ± 7.7	26.2 ± 5.9	0.927
Hepatitis Etiology, n (%)				0.300
Viral	4 (28.6)	9 (60)	13 (44.8)
Alcoholic	0	1 (6.7)	1 (3.5)
Dysmetabolic	3 (21.4)	1 (6.7)	4 (13.8)
Mixed	3 (21.4)	1 (6.7)	4 (13.8)
Other	4 (28.6)	3 (20)	7 (24.1)
Missing	1	-	1
Diabetes, n (%)				0.700
No	9 (60)	11 (73.3)	20 (66.7)
Yes	6 (40)	4 (26.7)	10 (33.3)
Heart disease, n (%)				0.330
No	11 (73.3)	14 (93.3)	25 (83.3)
Yes	4 (26.7)	1 (6.7)	5 (16.7)

TACE: Trans-Arterial ChemoEmbolization; BMI: Body mass index.